Capricor Therapeutics to Present at Upcoming Investor Conferences
Capricor Therapeutics(CAPR) Newsfilter·2024-03-21 12:30SAN DIEGO, March 21, 2024 (GLOBE NEWSWIRE) -- Capricor Therapeutics (NASDAQ:CAPR), a biotechnology company developing transformative cell and exosome-based therapeutics for the treatment and prevention of rare diseases, today announced that the Company is scheduled to present at two upcoming investor conferences. Event:H.C. Wainwright 2nd Annual Cell Therapy ConferencePresentation:March 26, 2024 at 2:00 p.m. ETFormat:Virtual fireside chat and one-on-one meetings Event:Cantor Fitzgerald's Muscular Dystrophy ...